ENDOTHELIAL OXIDATIVE STRESS AND eNOS UNCOUPLING AS DETERMINANTS OF THE LOSS OF ENDOTHELIUM-DEPENDENT VASODILATION IN EARLY CARDIOVASCULAR DISEASES
DOI:
https://doi.org/10.36557/2674-8169.2026v8n1p154-172Keywords:
Disfunção endotelial, Estresse oxidativo, Óxido Nítrico, ENOS, Doenças cardiovascularesAbstract
Introduction: Endothelial dysfunction emerges early in cardiovascular disease as a functional alteration preceding overt structural vascular lesions and is strongly shaped by redox imbalance and reduced nitric oxide bioavailability. Objectives: To integrate, from a mechanistic perspective, the physiological basis of endothelial signaling, the molecular mechanisms of oxidative stress and eNOS uncoupling, and their functional impact on endothelium-dependent vasodilation, with emphasis on early cardiovascular disease. Material and methods: Mechanistic narrative review of peer-reviewed literature from the last five years, in English, Portuguese, and Spanish, retrieved from indexed databases (PubMed/MEDLINE, Scopus, SciELO, and BVS), excluding grey literature and duplicates. Results: Endothelial oxidative stress decreases NO bioavailability through rapid chemical inactivation and impairment of NO–cGMP signaling, while promoting oxidation of critical cofactors. eNOS uncoupling represents a central inflection point by combining reduced NO synthesis with increased reactive oxygen species generation, reinforcing a self-sustained dysfunctional endothelial phenotype. Functionally, this drives progressive loss of endothelium-dependent vasodilation, with early hemodynamic and microvascular consequences detectable before advanced structural remodeling, thereby contributing to vascular stiffness and pro-inflammatory/pro-thrombotic shifts. Conclusions: The oxidative stress–eNOS uncoupling–loss of endothelium-dependent vasodilation axis constitutes a mechanistic continuum that shapes early cardiovascular disease. Coherent therapeutic strategies should target durable restoration of vascular redox balance, preservation of cofactors and NO–cGMP efficiency, and sustained eNOS recoupling.
Downloads
References
BISCONTI, A. V. et al. No effect of acute tetrahydrobiopterin supplementation on endothelial function in healthy subjects: role of the BH4/BH2 ratio. American Journal of Physiology – Heart and Circulatory Physiology, v. 322, n. 3, p. H407–H416, 2022. DOI: https://doi.org/10.1152/ajpheart.00633.2021.
DHUNGANA, G. et al. Role of nitric oxide and Nrf2 in counteracting vascular oxidative stress. Antioxidants, v. 14, n. 2, p. 256, 2025. DOI: https://doi.org/10.3390/antiox14020256.
DUBOSE, L. E. et al. Tetrahydrobiopterin deficiency as a mediator of oxidative stress and endothelial dysfunction. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology, v. 322, n. 2, p. R151–R164, 2022. DOI: https://doi.org/10.1152/ajpregu.00201.2021.
FEENSTRA, L. et al. Calciprotein particles induce endothelial dysfunction by oxidative stress and reduced nitric oxide bioavailability. Cardiovascular Research, v. 119, n. 6, p. 1324–1337, 2023. DOI: https://doi.org/10.1093/cvr/cvad032.
GONZALEZ, M. et al. Promotion of nitric oxide production: molecular mechanisms and therapeutic strategies. Frontiers in Cardiovascular Medicine, v. 12, p. 1298456, 2025. DOI: https://doi.org/10.3389/fcvm.2025.1298456.
JANASZAK-JASIECKA, A. et al. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms and therapeutic implications. Antioxidants & Redox Signaling, v. 38, n. 7–9, p. 423–447, 2023. DOI: https://doi.org/10.1089/ars.2023.0006.
LI, H. et al. Pharmacological targeting of endothelial nitric oxide synthase in cardiovascular disease. Pharmacological Research, v. 195, p. 106873, 2025. DOI: https://doi.org/10.1016/j.phrs.2025.106873.
MONTIEL, V. et al. Endothelial oxidative stress with decreased nitric oxide bioavailability in patients with early cardiovascular risk. Clinical Science, v. 136, n. 3, p. 195–210, 2022. DOI: https://doi.org/10.1042/CS20211043.
MÜNZEL, T. et al. Vascular redox signaling and endothelial nitric oxide synthase uncoupling in cardiovascular disease. Cardiovascular Research, v. 119, n. 2, p. 331–347, 2023. DOI: https://doi.org/10.1093/cvr/cvac174.
NEGRE-SALVAYRE, A. et al. Post-translational modifications of endothelial nitric oxide synthase in oxidative stress. Redox Biology, v. 54, p. 102347, 2022. DOI: https://doi.org/10.1016/j.redox.2022.102347.
PENNA, C. et al. Endothelial dysfunction: redox imbalance, NLRP3 inflammasome activation and cardiovascular disease. Cardiovascular Research, v. 121, n. 1, p. 22–36, 2025. DOI: https://doi.org/10.1093/cvr/cvad271.
RUAN, L. et al. The effect of varied exercise intensity on antioxidant function and aortic endothelial function. Arquivos Brasileiros de Cardiologia, v. 118, n. 5, p. 894–903, 2022. DOI: https://doi.org/10.36660/abc.20210123.
SHAITO, A. et al. Oxidative stress-induced endothelial dysfunction in cardiovascular disease. Frontiers in Bioscience – Landmark, v. 27, n. 3, p. 72, 2022. DOI: https://doi.org/10.31083/j.fbl2703072.
SHEN, Y. et al. FAM3D causes eNOS uncoupling through oxidative stress and contributes to hypertension. Hypertension, v. 81, n. 4, p. 1092–1104, 2023. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.122.20573.
SILVA, F. C. et al. Endothelial dysfunction due to inhibition of nitric oxide synthesis: an in vitro model. Frontiers in Physiology, v. 13, p. 978378, 2022. DOI: https://doi.org/10.3389/fphys.2022.978378.
SOFIULLAH, S. S. M. et al. Natural bioactive compounds targeting NADPH oxidase in cardiovascular diseases. Antioxidants, v. 12, n. 6, p. 1184, 2023. DOI: https://doi.org/10.3390/antiox12061184.
TRAN, N. et al. Endothelial nitric oxide synthase and vascular homeostasis. International Journal of Molecular Sciences, v. 23, n. 18, p. 10547, 2022. DOI: https://doi.org/10.3390/ijms231810547.
VALERIO, V. et al. Enduring reactive oxygen species emission causes aberrant protein S-glutathionylation and endothelial dysfunction. Free Radical Biology and Medicine, v. 186, p. 146–159, 2022. DOI: https://doi.org/10.1016/j.freeradbiomed.2022.04.012.
VILLADANGOS, L. et al. Subcellular localization guides endothelial nitric oxide synthase function. Cells, v. 13, n. 4, p. 347, 2024. DOI: https://doi.org/10.3390/cells13040347.
WANG, X. et al. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm, v. 5, n. 1, p. e423, 2024. DOI: https://doi.org/10.1002/mco2.423.
YANG, L. et al. Treatment of endothelial cell dysfunction in atherosclerosis. Frontiers in Cardiovascular Medicine, v. 12, p. 1310045, 2025. DOI: https://doi.org/10.3389/fcvm.2025.1310045.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jorge Eberson de Oliveira Santana, Ana Clara Alves Gomes, Bianca Leite De Araújo Petrônio , Davi Araújo de Morais, Dayro Rodrigues de Lima Coutinho, Emanuel Levi Da Silva , Iara Sousa Moura, Maria Alice Santos Nardini, Maria Gabriella Cavalcante de Lima , Maria Letícia Santana Matos, Sara Araújo de Morais

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



